The largest database of trusted experimental protocols

Cobas e411 device

Manufactured by Roche
Sourced in Germany

The Cobas E411 is an automated analyzer device designed for in vitro diagnostic testing. It is capable of performing electrochemiluminescence immunoassay (ECLIA) analysis on a variety of samples. The core function of the Cobas E411 is to automate the process of sample analysis and result generation for clinical chemistry and immunology testing.

Automatically generated - may contain errors

5 protocols using cobas e411 device

1

Comprehensive Blood Biomarkers Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Red cell distribution width was measured in blood samples collected in EDTA tubes, which were analyzed with an automated hematology analysis system (Mindray BC5800). Normal RDW values ranged from 11% to 16% in our laboratory. Standard laboratory parameters, including total leukocyte and neutrophil counts, hematocrit, glucose and creatinine levels and lipid profiles, were determined with standard methods. Plasma NT-proBNP levels were measured using a Cobas e411 device (Roche, Germany) via the immunoassay method. The NT-proBNP reference values were determined as 0–125 pg/ml. Hs-CRP was measured using a BN2 model nephelometer.
+ Open protocol
+ Expand
2

Serum PCT Levels in ICU Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum PCT levels were measured with the electrochemiluminescence immunoassay method with a Roche Cobas E411 device. The PCT levels for patients were recorded on the TTM reporting forms on admission to ICU and in 24 and 48 hours were also included in the assessment.
+ Open protocol
+ Expand
3

Polycystic Ovarian Morphology in Early Follicular Phase

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the early follicular phase (days 3–5) of spontaneous bleeding or withdrawal bleeding induced by medroxyprogesterone acetate, laboratory assessments and ultrasound sonographies were performed.
All participants underwent abdominal ultrasonography by a sonologist; ovaries containing 12 or more follicles measuring 2–9 mm in diameter and/or enlarged ovarian volume (> 10 mm3) were considered as a positive polycystic sonographic morphology [6 (link)].
All blood samples’ test was done after 8-h fasting and overnight bed rest in Arash Hospital laboratory. The laboratory investigation consisted of Sex Hormone-Binding Globulin (SHBG), Total Testosterone (TT) levels, and Free Androgen Index (FAI) which were computed by TT (nmol/L)/SHBG (nmol/L) × 100). Hyper androgenism was defined as TT greater than 0.68 ng/ml was greater than 5.36%. All of the above tests were assessed by commercial kits (Pars Azmoon Inc., Tehran, Iran) using Auto-analyzer BT2000 device. Biochemical measurement of TT and SHBG levels was carried out using Cobas E411 device based on electro-chemiluminescence method (Roche Instr Kit, Germany).
+ Open protocol
+ Expand
4

Serum Biomarker Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum PCT levels were measured with the electrochemiluminescence immunoassay method using a Roche Cobas E411 device at a reference range of 0.04–0.1 µg/L. Serum CRP levels were assayed via the nephelometric method using the Beckman Array 360 System at a reference range of 0–5 mg/L. The WBC count was determined using a hematological cell counter (LH 780 Analyzer, Beckman Coulter Inc., Miami, FL, USA) at a reference range of 4.2–10.6 × 103/µL.
+ Open protocol
+ Expand
5

sFlt-1 and PlGF Biomarkers Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The measurements of angiogenesis-related factors sFlt-1 and PlGF in peripherical blood were performed in the Roche Cobas e411 device (ROCHE®), with automated Elecsys® sFlt-1/PlGF kits (ROCHE®), using 50 μL of maternal serum, through immunoassays for the quantitative determination of such biomarkers based on electrochemiluminescence technology. The protocol was implemented according to the manufacturer instructions. The concentration results obtained by the assay were expressed in pg of the analyte per mL of serum - pg/mL. The values obtained were also used for the calculation of sFlt-1/PlGF ratio. The sFlt-1/PlGF ratio had a threshold implemented of 38 for statistical analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!